BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 22513084)

  • 1. The effects of increased expression of DLK1 gene on the pathogenesis of myelodysplastic syndromes.
    Ma X; Zhang Y; Yang L; Xu Z; Xiao Z
    Clin Lymphoma Myeloma Leuk; 2012 Aug; 12(4):261-8. PubMed ID: 22513084
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expression of Dlk1 gene in myelodysplastic syndrome determined by microarray, and its effects on leukemia cells.
    Qi X; Chen Z; Liu D; Cen J; Gu M
    Int J Mol Med; 2008 Jul; 22(1):61-8. PubMed ID: 18575777
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dlk1 in normal and abnormal hematopoiesis.
    Sakajiri S; O'kelly J; Yin D; Miller CW; Hofmann WK; Oshimi K; Shih LY; Kim KH; Sul HS; Jensen CH; Teisner B; Kawamata N; Koeffler HP
    Leukemia; 2005 Aug; 19(8):1404-10. PubMed ID: 15959531
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Gene expression in patients with myelodysplastic syndrome].
    Chen BA; Zhang B; Gao C; Gao F; Xia GH; Shao ZY; Ding JH; Zhao G; Chen J; Wang J; Song HH; Bao W; Zhong YJ; Pei XP; Wang F; Gu ZZ
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2010 Jun; 18(3):666-70. PubMed ID: 20561424
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [TET2 and DLK1 gene expression and their clinical significance in bone marrow CD(3)(+) T cells of patients with myelodysplastic syndrome].
    Zhang W; Fu R; Wang HQ; Li LJ; Yue LZ; Liu H; Qu W; Liang Y; Wang GJ; Wang XM; Wu YH; Liu H; Song J; Guan J; Xing LM; Shao ZH
    Zhonghua Nei Ke Za Zhi; 2012 Jul; 51(7):543-6. PubMed ID: 22943828
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Transcriptional down-regulation of the Wnt antagonist SFRP1 in haematopoietic cells of patients with different risk types of MDS.
    Reins J; Mossner M; Neumann M; Platzbecker U; Schumann C; Thiel E; Hofmann WK
    Leuk Res; 2010 Dec; 34(12):1610-6. PubMed ID: 20471677
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Distinct expression profiles of MSI2 and NUMB genes in myelodysplastic syndromes and acute myeloid leukemia patients.
    Pereira JK; Traina F; Machado-Neto JA; Duarte Ada S; Lopes MR; Saad ST; Favaro P
    Leuk Res; 2012 Oct; 36(10):1300-3. PubMed ID: 22784712
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Survivin expression in "low-risk" and "high-risk" myelodysplastic syndromes.
    Gianelli U; Fracchiolla NS; Cortelezzi A; Pellegrini C; Savi F; Moro A; Grimoldi MG; Deliliers GL; Coggi G; Bosari S
    Ann Hematol; 2007 Mar; 86(3):185-9. PubMed ID: 17124585
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Overexpression of delta-like (Dlk) in a subset of myelodysplastic syndrome bone marrow trephines.
    Länger F; Stickel J; Tessema M; Kreipe H; Lehmann U
    Leuk Res; 2004 Oct; 28(10):1081-3. PubMed ID: 15289021
    [TBL] [Abstract][Full Text] [Related]  

  • 10. GATA-1 transcription factor is up-regulated in bone marrow hematopoietic progenitor CD34(+) and erythroid CD71(+) cells in myelodysplastic syndromes.
    Maratheftis CI; Bolaraki PE; Voulgarelis M
    Am J Hematol; 2007 Oct; 82(10):887-92. PubMed ID: 17570514
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genomic loss of EZH2 leads to epigenetic modifications and overexpression of the HOX gene clusters in myelodysplastic syndrome.
    Xu F; Liu L; Chang CK; He Q; Wu LY; Zhang Z; Shi WH; Guo J; Zhu Y; Zhao YS; Gu SC; Fei CM; Li X
    Oncotarget; 2016 Feb; 7(7):8119-30. PubMed ID: 26812882
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Overexpression of MCM2 in myelodysplastic syndromes: association with bone marrow cell apoptosis and peripheral cytopenia.
    Suzuki S; Kurata M; Abe S; Miyazawa R; Murayama T; Hidaka M; Yamamoto K; Kitagawa M
    Exp Mol Pathol; 2012 Feb; 92(1):160-6. PubMed ID: 22115939
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression of DLK1 Gene in the Bone Marrow Cells of Patients with Myelodysplastic Syndromes and Its Clinical Significance.
    Yue LZ; Fu R; Wang HQ; Li LJ; Ruan EB; Wang GJ; Qu W; Liang Y; Guan J; Wu YH; Liu H; Song J; Wang XM; Xing LM; Shao ZH
    Cancer Biol Med; 2012 Sep; 9(3):188-91. PubMed ID: 23691477
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evi-1 and MDS1-Evi-1 genes in pathogenesis of myelodysplastic syndromes and post-MDS acute myeloid leukemia.
    Xu K; Wang L; Hao Y; Shao Z; Meng Q; Li K; Chao H; Tang K; Wang L
    Chin Med J (Engl); 1999 Dec; 112(12):1112-8. PubMed ID: 11721451
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Akt/mammalian target of rapamycin signal transduction pathway is activated in high-risk myelodysplastic syndromes and influences cell survival and proliferation.
    Follo MY; Mongiorgi S; Bosi C; Cappellini A; Finelli C; Chiarini F; Papa V; Libra M; Martinelli G; Cocco L; Martelli AM
    Cancer Res; 2007 May; 67(9):4287-94. PubMed ID: 17483341
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Over-expression of tumor necrosis factor-alpha in bone marrow biopsies from patients with myelodysplastic syndromes: relationship to anemia and prognosis.
    Stifter G; Heiss S; Gastl G; Tzankov A; Stauder R
    Eur J Haematol; 2005 Dec; 75(6):485-91. PubMed ID: 16313260
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Toll-like receptor-4 is up-regulated in hematopoietic progenitor cells and contributes to increased apoptosis in myelodysplastic syndromes.
    Maratheftis CI; Andreakos E; Moutsopoulos HM; Voulgarelis M
    Clin Cancer Res; 2007 Feb; 13(4):1154-60. PubMed ID: 17317824
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Matrix metalloproteinase production by bone marrow mononuclear cells from normal individuals and patients with acute and chronic myeloid leukemia or myelodysplastic syndromes.
    Ries C; Loher F; Zang C; Ismair MG; Petrides PE
    Clin Cancer Res; 1999 May; 5(5):1115-24. PubMed ID: 10353746
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bone marrow stromal cells from MDS and AML patients show increased adipogenic potential with reduced Delta-like-1 expression.
    Weickert MT; Hecker JS; Buck MC; Schreck C; Rivière J; Schiemann M; Schallmoser K; Bassermann F; Strunk D; Oostendorp RAJ; Götze KS
    Sci Rep; 2021 Mar; 11(1):5944. PubMed ID: 33723276
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [mRNA expression of notch ligand-delta-like-1 and jagged-1 in mesenchymal stem cells of MDS patients].
    Fei CM; Gu SC; Zhao YS; Guo J; Li X; Chang CK
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2014 Dec; 22(6):1656-60. PubMed ID: 25543492
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.